Hepatitis C: all 2,356 studies
Page 23 of 24. Open to participants first (101), then studies with results posted, then the rest; newest registration first within each.
- MYPROMS-ES02: Safety and Efficacy of Basiliximab, Cyclosporine Microemulsion and Enteric-coated Mycophenolate Sodium (EC-MPS) Versus EC-MPS and Steroid Therapy in Kidney Transplant Recipients Who Are Hepatitis C PositiveTerminatedNCT00284921Phase 3
- The Role of Bacterial Overgrowth and Delayed Intestinal Transit in Hepatic EncephalopathyStatus unknownNCT00281502Phase 2
- Buprenorphine Versus Methadone Maintenance in Hepatitis C Patients Receiving Peg-Intron and Rebetol (Study P04279)(TERMINATED)TerminatedNCT00279565Phase 4
- Pegylated Interferon and Ribavirin Therapy in Chronic Hepatitis Genotype 4CompletedNCT00277862Phase 4
- Safety Study of Low Dose Interleukin 2 (IL-2) Plus PEG-IFN/RBV In Chronic Hepatitis C Virus Genotype ITerminatedNCT00277758Phase 1
- CPG10101 Combination Therapy For The Treatment Of Hepatitis C In Non-Responder (Null And Partial Responder) Hepatitis C Virus (HCV) Genotype 1 Infected SubjectsCompletedNCT00277238Phase 2
- Safety and Effectiveness Using Pegasys and Copegus in Recipients of Liver Transplantation With Hepatitis CCompletedNCT00275548Phase 4
- Assessing the Efficacy and Safety of Rosiglitazone Added to Standard Therapy for Hepatitis C Genotype 1 With Fatty LiverTerminatedNCT00274495Phase 4
- Treatment With IFN After Curative Resection of HCC in HCV-Related CirrhosisCompletedNCT00273247Phase 3
- Prediction of Response to Treatment of Patients With Chronic HCV Infection by Genetic ProfileStatus unknownNCT00272389
- Study of High Dosage CIFN Plus RBV for HCV Genotype 1 Infected Patients Who Are Nonresponders to Prior TherapyCompletedNCT00266318Phase 4
- Phase 2 Study of VX-950, Pegasys and Copegus in Hepatitis CCompletedNCT00262483Phase 2
- Use or Non-use of Epoetin Beta in Patients Infected by Chronic Hepatitis CCompletedNCT00262379Phase 3
- Safety, Tolerability and Efficacy of XTL 2125 in HCV-Infected Patients Who Are Interferon-Alpha Non-Responders or RelapsersWithdrawnNCT00255359Phase 1
- Peginterferon Alpha-2a Maintenance Therapy for Portal Hypertension in Patients With Hepatitis CCompletedNCT00252642Not applicable
- VX-950 and Peginterferon for Hepatitis CCompletedNCT00251199Phase 1
- A Multicenter Phase 3 Study of Interferon-beta-1a for the Treatment of Chronic Hepatitis C in Asian SubjectsCompletedNCT00249860Phase 3
- Bridging Active Heroin Users to Hepatitis C Treatment Using Buprenorphine - 1CompletedNCT00249574Not applicable
- Trial of Peg-interferon Plus Epoetin-alfa for Treatment of Chronic Hepatitis C Virus InfectionCompletedNCT00248339Phase 3
- Pender Assisted Therapy (PATh) - Prospective Study of the Treatment of HCVCompletedNCT00247884
- A Clinical Research Study Designed To Determine If Treatment of Hepatitis C With Milk Thistle is More Effective Than No Treatment In Patients Infected With Both HIV And Hepatitis CCompletedNCT00246363Phase 1/2
- Trial of Pegasys® in Patients With Chronic Hepatitis CCompletedNCT00245414Phase 4
- A Video-Based HCV Curriculum for Active Injection Drug UsersCompletedNCT00241943Not applicable
- A Video-Based HCV Curriculum for Drug UsersCompletedNCT00241917Not applicable
- Timing and Duration of Acute Hepatitis C TreatmentCompletedNCT00241618Phase 4
- Comparison in Efficacy and Safety Between Interferon Alfacon-1 Alone and Concomitant Dosing With Ribavirin for the Treatment of Hepatitis CCompletedNCT00239252Phase 3
- Effect of Infliximab on the Efficacy of Peg-Intron/Ribavirin in Patients With Hepatitis C (Study P04257AM4)(COMPLETED)CompletedNCT00237484Phase 3
- Study of the Immune Response to Hepatitis C VirusCompletedNCT00237432
- Study of Viramidine to Ribavirin in Patients With Chronic Hepatitis C Who Are Treatment-NaiveCompletedNCT00230958Phase 3
- Study in Non-responder Hepatitis C Genotype 1 Patients With EMZ702, Pegylated Interferon and RibavirinCompletedNCT00230854Phase 1
- Study of AVI-4065 in Healthy Volunteers and Chronic Active HCV PatientsTerminatedNCT00229749Phase 1/2
- Health Behavior Feedback Study for Veterans With Hepatitis CCompletedNCT00229580Phase 1
- Dose Escalation Study to Evaluate the Safety and Antiviral Activity of Val-mCyd in Adults With Chronic Hepatitis CCompletedNCT00227435Phase 1/2
- Long-Term Evaluation Follow-up of Neurocognitive Performance and Emotional State in Patients With Chronic Hepatitis CCompletedNCT00227149
- 4-Methylumbelliferone as a Treatment for Chronic HBV/HCVStatus unknownNCT00225537Phase 2
- Reasons for Non-treatment of Hepatitis C in HCV Mono-infected Patients Versus HCV-HIV Co-infected Patients in a University SettingCompletedNCT00222859
- Treatment of Chronic Hepatitis C With PEG Interferon alfa2a and Ribavirin in HIV-infected PatientsCompletedNCT00221650Phase 2
- Peginterferon Alfa-2a Plus Ribavirin Plus Amantadine for the Treatment of Hepatitis C Infected PatientsCompletedNCT00221624Phase 3
- Hepatitis C Virus and the Humoral Immune SystemCompletedNCT00219999
- Preventing Depression in Methadone Maintenance Patients Receiving Hepatitis C Treatment - 1CompletedNCT00218556Not applicable
- A Trial to Reduce Hepatitis C Among Injection Drug Users - 1CompletedNCT00218192Phase 3
- A Study to Evaluate the Safety and Efficacy of Celgosivir and Peginterferon Alfa-2b, With or Without Ribavirin, in Patients With Chronic Hepatitis C Genotype 1 InfectionCompletedNCT00217139Phase 2
- Comparative Trial of Standard Versus Low-dose Peg-Interferon Plus Ribavirin in the Treatment of Chronic Hepatitis CCompletedNCT00216775
- PEG-Interferon a-2b + Ribavirin for Treatment of Chronic HRN 005 Hepatitis C Infection in HIV-Infected Persons Not Previously Treated With InterferonCompletedNCT00215891Phase 3
- PEG-Interferon a-2b + Ribavirin for Treatment of Patients With Chronic Hepatitis C Who Have Previously Failed to Achieve a Sustained Virologic Response Following Interferon Alfa or Interferon a-2b + Ribavirin TherapyCompletedNCT00215865Phase 3
- HRN 004- Peginterferon a-2a Plus Ribavirin for Chronic Hepatitis C Infection in HIV Infected Persons Who Have Failed to Achieve a Sustained Virologic Response Following Previous Interferon TherapyStatus unknownNCT00215839Phase 3
- Study of the Role of Dendritic Cells in the Recurrence of Hepatitis C After Liver Transplantation. Analysis of Hepatitis C Virus (HCV) Quasispecies Evolution.Status unknownNCT00213707
- Antiviral & Antifibrotic Liver Therapy in HCV + Drinkers and Non-DrinkersCompletedNCT00211848Phase 2
- Hepatitis C Treatment of InmatesTerminatedNCT00209898Phase 4
- Plasma Ribavirin Assay During Combination Therapy for Chronic Hepatitis CTerminatedNCT00209755Not applicable
- Paroxetine for the Treatment of Interferon Related Side Effects for Hepatitis CCompletedNCT00209118Not applicable
- Infergen, Ribavirin & Avandia in Previous Relapsers or Nonresponders to Pegylated Interferon and RibavirinCompletedNCT00207402Phase 4
- Does Induction PEG-Intron in Combination With Rebetol Enhance the Sustained Response Rates in Patients With CHCCompletedNCT00207363Phase 4
- Study for the Treatment of Significant Steatosis With Xenical Followed by Treatment of Hepatitis C With Pegasys/CopegusCompletedNCT00207311Phase 4
- Impact of Moderate Alcohol Use on Hepatitis C Virus (HCV) ProgressionCompletedNCT00205075
- Pegylated Interferon Plus Ribavirin in the Treatment of Active and Past Intravenous Drug Users Infected With Hepatitis CCompletedNCT00203606Phase 4
- Efficacy of Paroxetine in the Prevention of Depressive Syndrome in Patients With Chronic Hepatitis C Treated by PEG-Interferon Alfa Plus RibavirinCompletedNCT00196664Phase 3
- Efficacy and Safety of Addition of IL-2 to Pegylated Interferon Alpha 2a and Ribavirin in HIV/HCV Coinfected PatientsCompletedNCT00196586Phase 2
- Treatment of Anemia and Neutropenia in HIV/HCV Coinfected Patients Treated With Pegylated Interferon and RibavirinTerminatedNCT00194857Phase 4
- Treatment of Acute Hepatitis C Virus Infection With Pegylated Interferon in Injection Drug UsersCompletedNCT00194480Phase 4
- Australian Trial in Acute Hepatitis CCompletedNCT00192569Phase 4
- Pioglitazone in Hepatitis CCompletedNCT00189163Phase 4
- Insulin Resistance Associated With Chronic Hepatitis C (CHC) and the Effect of Antiviral TherapyStatus unknownNCT00188240Not applicable
- Neurocognitive Functioning in Patients With Hepatitis C Pre- and Post-Treatment With Antiviral MedicationStatus unknownNCT00188201
- Natural History of Hepatitis C in Patients With Normal Liver TestsCompletedNCT00187473
- Interferon Treatment for Patients With Chronic Hepatitis C and End Stage Renal DiseaseCompletedNCT00172809Phase 4
- MMF Influence on HCV Viral Evolution After Liver TransplantationCompletedNCT00170131
- Orthotopic Liver Transplant (OLT) Recipients With Hepatitis C Virus (HCV) Under Preemptive TreatmentWithdrawnNCT00167557Phase 4
- Immune Response to Hepatitis C VirusWithdrawnNCT00165919
- Behavioral Intervention for HIV and HCV-Uninfected Injection Drug UsersCompletedNCT00164372Phase 2/3
- Pharmacogenomics of Interferon and Ribavirin Treatment in Patients With Chronic Hepatitis C Virus InfectionStatus unknownNCT00164073
- Associations, Outcomes and Genomics of GB Virus C, Hepatitis C Virus and Human Immunodeficiency Virus InfectionTerminatedNCT00164060
- Daily-Dose Consensus Interferon and Ribavirin: Efficacy of Combined TherapyCompletedNCT00162734Phase 3
- Differential Gene Expression of Liver Tissue and Blood From Individuals With Chronic Viral HepatitisStatus unknownNCT00160940
- Liver Transplantation in Patients With Hepatitis C Virus (HCV) and Human Immunodeficiency Virus (HIV) CoinfectionTerminatedNCT00158535Phase 2
- Efficacy of Pegylated Interferon Alone in Egyptian Patients With Acute Hepatitis C (ANRS 1213)CompletedNCT00158522Phase 3
- Chronic Hepatitis C Treatment by Pegylated Interferon and Ribavirin in Naive Egyptian Patients (ANRS 1211)CompletedNCT00158496Phase 3
- A Study to Evaluate the Safety and Efficacy of Celgosivir in Patients With Chronic Hepatitis C Genotype 1 InfectionCompletedNCT00157534Phase 2
- Peginterferon Alfa-2a Plus Ribavirin for Chronic Hepatitis C/Hepatitis B Co-Infection and Chronic Hepatitis CStatus unknownNCT00154869Phase 3
- Identification of Biomarkers Associated With Human Hepatocellular Carcinoma by SELDIStatus unknownNCT00154531
- Analysis of the Duration of Combination Therapy That is Necessary for HCV Genotype 1 EradicationCompletedNCT00152581Phase 4
- Treatment of Recurrent Hepatitis C After Liver TransplantationCompletedNCT00151580Phase 3
- Peginterferon and Ribavirin on Virologic and Immunologic Parameters in Hepatitis C Mono- and Coinfected Patient (PRIVICOP)CompletedNCT00150904
- Interferon Gamma With Peg-Interferon Alpha 2a and Ribavirin in Non Responders Patients With Chronic Hepatitis CCompletedNCT00148863Phase 2
- Improving Hepatitis C Treatment in Injection Drug UsersCompletedNCT00148031Phase 4
- HEPMET-1: Evaluate the Feasibility, Mental Sideeffects and the Efficacy of Hepatitis C Treatment in a MMT Group.CompletedNCT00147784Phase 3
- Study on Chronic Hepatitis C Treatment With Interferon Alpha, Ribavirin and Amantadine in Naive PatientsCompletedNCT00146016Phase 3
- A Study of Peginterferon Alfa-2a in Combination With Ribavirin in Patients With Chronic Hepatitis CCompletedNCT00144469Phase 3
- Multicenter Study Evaluating 12 Versus 24 Weeks Therapy With Peginterferon and Ribavirin for Hepatitis C Virus (HCV) Genotype 2 or 3CompletedNCT00143000Phase 4
- CPG10101 Combination Therapy For The Treatment Of Hepatitis C In Relapsed Hepatitis C Virus (HCV) SubjectsCompletedNCT00142103Phase 1
- An Open Label Study To Evaluate The Safety and Kinetics of Nelfinavir in Subjects With HIV and Hepatitis CCompletedNCT00141284Phase 4
- Prophylaxis of Psychiatric Symptoms During Anti-HCV TreatmentCompletedNCT00133276Phase 2/3
- Pegylated Interferon Therapy for Acute Hepatitis C Infection in HIV-infected PatientsCompletedNCT00132210Phase 4
- Study of Bavituximab in Patients With Chronic Hepatitis C Virus InfectionCompletedNCT00128271Phase 1
- Peginterferon Alfa-2a, Ribavirin, Amantadine/Placebo in Hepatitis C Virus (HCV)-Genotype-1-Infection (PRAMA)Status unknownNCT00127777Phase 4
- Safety and Efficacy of the Therapeutic Vaccine GI-5005 Versus Placebo for the Treatment of Chronic Hepatitis C InfectionCompletedNCT00124215Phase 1
- Triple Therapy With Peg-Interferon Alfa-2b/Ribavirin Plus Amantadine Compared to Standard Peg-Interferon Alfa-2b/Ribavirin for Previous Hepatitis C Virus (HCV) Non RespondersTerminatedNCT00122629Phase 3
- Efficacy of Pegylated Interferon on Liver Fibrosis in Co-infected Patient With HIV and Hepatitis CCompletedNCT00122616Phase 3
- A Study Exploring an Induction-Maintenance Kaletra-Based Therapy Versus a Sustiva-Based Regimen in Previously Non-Treated, HIV-1/HCV Co-Infected SubjectsWithdrawnNCT00121017Phase 2
- Valopicitabine Alone and Together With Pegylated Interferon in Patients With Chronic Hepatitis C Who Have Failed to Respond to Standard TherapyCompletedNCT00120861Phase 2